The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic profiling of prostate cancer at a diverse academic center.
 
Robert Lopez
No Relationships to Disclose
 
Anna C. Ferrari
Stock and Other Ownership Interests - Exelixis (I); TAKEDA
Consulting or Advisory Role - Astellas Pharma; Auven Therapeutics; Bayer; Medivation
Research Funding - Dendreon (Inst); Novartis (Inst); Orion (Inst); Oxford Biomedica (Inst); SOTIO (Inst)
 
Sanjay Goel
Research Funding - BeiGene (Inst); Oncolytics (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364
 
Stephen Peeke
No Relationships to Disclose
 
Janaki Neela Sharma
No Relationships to Disclose
 
Niraj Konchady Shenoy
No Relationships to Disclose
 
Benjamin Adam Gartrell
No Relationships to Disclose